Skip to main content
A healthcare professional in white coat speaking with a smiling patient in the hallway of a clinic.

What a lifetime of stroke protection looks like

Your referral. Their freedom from OACs.

For your patients with non-valvular AFib, managing stroke risk often means lifelong oral anticoagulants (OACs). But what if there was an alternative? The WATCHMAN™ Left Atrial Appendage Closure (LAAC) Implant is a minimally invasive, one-time procedure designed to protect AFib patients from the risk of stroke for the rest of their lives—without the bleeding risks associated with long-term OACs.

Your referral can make a difference, for a lifetime.

Explore referral information
A smiling woman in a pink top and jeans holding hands with a young girl in a superhero costume.
An orange checkbox icon.

Proven1

10 years

FDA approved

20+

years clinical experience

An orange shield icon with a heart in it.

Safe2

99%

implant success rate*

0.5%

major adverse event rate†

An orange spinning gear icon.

Effective2

96.2%

of patients discontinued OACs at 45 days

Which of your AFib patients may benefit from the WATCHMAN Implant?

The WATCHMAN Implant may be suitable for a broad range of non-valvular AFib (NVAF) patients. See examples of different types of patients who may be appropriate WATCHMAN Implant candidates.

Image of a potential patient with icons indicating a previous bleed and future bleed risk.

Example 1: Previous major bleeding

Patient is at risk for stroke and has had a previous major bleeding event.

Image of a potential patient with icons indicating a previous bleed and drug interaction.

Example 2: Cannot tolerate long-term OACs

Patient has a history of minor bleeding and comorbidities that may not be compatible with OACs.

Image of a potential patient with icons indicating a future bleed risk and a stroke risk.

Example 3: High risk of future bleed

Patient has history of frequent falls and low time in therapeutic range.

Image of a potential patient with icons indicating a non-compliant, lifestyle and occupation, and stroke risk.

Example 4: Non-compliance

Patient is at risk for stroke but declines OACs.

Explore patient types
A closeup image of the WATCHMAN FLX Pro implant on a gray background
600,000+

Over 600,000 AFib patients have left OACS behind with the WATCHMAN LAAC Implant.1

One referral. A lifetime of protection.

Protection against stroke risk. Protection against OAC bleed risk. Your referral really can make a difference—and it all starts here, with tools and resources designed to help streamline your workflow.

IDENTIFY

Identify patients who may be a candidate for WATCHMAN

Here is a quick and easy checklist to help you get started.

Patient screening form

EDUCATE

Educate patients about alternatives to OACs

Share the benefits of living OAC-free for the rest of their lives.

Patient education and support

REFER

Refer patients for a WATCHMAN consultation

Find a list of qualified WATCHMAN Implant centers in your area.

Implant center locator

One Time. For a Lifetime.

*Procedure success defined as successful delivery and release of a WATCHMAN FLX Device into the LAA.
†Occurrence of one of the following events between the time of implant and within 7 days following the procedure or by hospital discharge, whichever is later: all-cause death, ischemic stroke, systemic embolism, or device or procedure related events requiring open cardiac surgery or major endovascular intervention.

References: 

1. Represents all WATCHMAN models.
2. Kar, S., et al, Primary Outcome Evaluation of the Next Generation LAAC Device: Results from the PINNACLE FLX Trial, Circulation, 2021.